For a long time, we’ve known that stem cells are special. But, for people suffering from Multiple Sclerosis these micro building blocks might hold the key to a healthier future.
Ottawa neurologist, Dr. Mark Freedman, and his team at the Sclerosis Research Unit at the Ottawa Hospital are leading the first Canadian clinical trial into the use of Mesenchymal Stem Cells (MSCs) for MS.
The trial focused on the therapeutic potential of these cells and the possibility that these MSCs might be able to repair nerves damaged by MS. In addition to the potential for repair that these cells offer, scientists are hoping to see a reduction in inflammation as well as healing.
A total of 9 countries, worldwide, are taking part in this study. With one of the highest rates of MS in the world, Canada is watching closely and hoping for positive results.
Winnipeg will be the other Canadian center conducting the trial. Under the leadership of Dr. James J Marriott at the University of Manitoba, 20 Canadian patients will be enrolled in the city. In total, 40 Canadians will take part in this innovative trial.
In June, Insception Lifebank is marking our 1-year anniversary of our Cord Tissue Program. When parents bank their children’s cord blood and cord tissue, they are saving both hematopoietic and MSC stem cells from their newborn. These cells have different and important uses. We hope you’ll celebrate with us by banking cord tissue for your little one.
In honour of the first year of this program, we’re offering all expecting parents who bank cord blood AND cord tissue between May 15th and June 30th, 2015 a Phil and Ted’s Lobster Chair (valued at $90.00).
Follow the link to learn more about the MESCAMS Clinical Trial.